Treating acute ileofemoral DVT by mechanical trombectomy with Aspirex Device
Phase 3
- Conditions
- Deep vein thrombosis.Deep vein thrombosis NOS
- Registration Number
- IRCT2016102630508N1
- Lead Sponsor
- Vice Chancellor for research of Guilan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
all the patients aged less than 60 years old with the onset of symptoms less than 2 weeks that initial diagnosis of acute ileofemoral deep vein thrombosis has been made by Doppler ultrasound and definite diagnosis has been made by venography and are a candidate for treatment
Exclusion criteria: patients with heart, renal or pulmonary failure; and the patients with the diagnosis of DVT after two weeks of symptoms onset
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Duration of the treatment. Timepoint: During hospitalization. Method of measurement: The time recorded in the checklist.;The success rate of the treatment. Timepoint: During hospitalization after treatment. Method of measurement: venography.
- Secondary Outcome Measures
Name Time Method Duration of hospitalization. Timepoint: During hospitalization. Method of measurement: The time recorded in the checklist.;Complications during the treatment. Timepoint: During treatment. Method of measurement: Physical examination and Lab tests.;Complete Thrombus lysis. Timepoint: During hospitalization after treatment. Method of measurement: Venography.;Improvement of the primary symptoms. Timepoint: During hospitalization, 2 weeks, 1 month, 45 days and 6 manoths after intervention. Method of measurement: Physical examination.;Complications during hospitalization. Timepoint: During hospitalization. Method of measurement: Physical examination and Lab tests.